Le Lézard
Classified in: Health, Science and technology
Subject: ACC

Report from Extraordinary General Meeting of Minesto AB


GOTHENBURG, Sweden, March 14, 2024 /PRNewswire/ -- An Extraordinary General Meeting in Minesto AB was held today, March 14, 2024, at MAQS Advokatbyrås premises at Östra Hamngatan 24 in Gothenburg. Chairman of the General Meeting was lawyer Eric Ehrencrona from MAQS Advokatbyrå.

The following main resolution was resolved upon at the Extraordinary General Meeting:

Approval of the Board of Directors' resolution on a new issue of units with preferential rights for existing shareholders

The Extraordinary General Meeting resolved to approve the Board of Directors' resolution from 26 February 2024 on a new issue of so-called units, consisting of shares and warrants of series TO4, with preferential rights for existing shareholders.

The complete proposal of the Board of Directors is available on the company's website, www.minesto.com

Please note:

The English text is an uncertified translation and in the event of any inconsistency between the English text and the Swedish text, the Swedish text shall prevail.

For additional information, please contact

Cecilia Sernhage, Chief Communications Officer
+46 735 23 71 58
[email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/minesto-ab/r/report-from-extraordinary-general-meeting-of-minesto-ab,c3946117

The following files are available for download:

https://mb.cision.com/Main/14621/3946117/2670555.pdf

Report from extraordinary general meeting Minesto

 


These press releases may also interest you

at 01:27
GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual...

at 01:25
Salmon Evolution ASA ("Salmon Evolution" or the "Company", OSE: SALME) reported operating revenues of NOK 100.3 million in the first quarter of 2024 and a group EBITDA of NOK 24.1 million. The first quarter constitutes a significant milestone for...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced that the Company will hold a conference call on Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business...

at 01:05
Galderma today announced that it has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic dermatitis in Australia, Singapore, Switzerland, and...

at 01:00
In an unprecedented partnership  between space and architectural innovation, Lonestar Data Holdings Inc. (Lonestar) and the world-renowned architectural firm Bjarke Ingels Group (BIG) proudly present the newly designed Freedom Payload, the first data...

at 00:45
Q1 2024 Results Further strong market share gains, disciplined execution Revenues flat yoy, outperforming markets; Adecco's relative revenue growth +600 bpsBy GBU, Adecco, +1% yoy, of which APAC +14%, Southern Europe & EEMENA +8%, DACH +7%; LHH -5%,...



News published on and distributed by: